Arrhythmias & electrophysiology

Predictive value of sudden cardiac death risk stratification for outcomes of catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy

Heart RhythmPublished study

Authors' conclusion

M-HR of SCD in HCM was associated with a higher recurrence rate after CA of AF.

Study context

Population
Patients with hypertrophic cardiomyopathy (HCM) who underwent catheter ablation (CA) of atrial fibrillation (AF), classified by the HCM risk-SCD modelincluded of 417 patients with HCM screened among 23,904 patients who underwent CA of AF
Participants
339 patients
Comparison
Long-term outcomes were compared between the groups.
  • Low-risk (LR) groupn = 292reference
  • Medium- to high-risk (M-HR) groupn = 47
Outcome
Recurrence rate after a single procedure
Follow-up
Median 43.0 months (12.0-69.0)

Main finding

As reported in the abstract

P < 0.001

Further findings

Recurrence rate after the last ablation · higher in the M-HR group

P < 0.001

Cardiac death · During follow-up · no significant difference

P = 0.995

Heart failure hospitalization · During follow-up · no significant difference

P = 0.471

Stroke · During follow-up · no significant difference

P = 0.071

OutcomeHazard ratio (95% CI)P value
Recurrence (multivariate analysis)M-HR of SCD was an independent predictor of recurrence · multivariate analysis1.77 (1.14–2.74)P = 0.010

Original publication

Predictive value of sudden cardiac death risk stratification for outcomes of catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy. Heart Rhythm. Published 22 July 2025. doi:10.1016/j.hrthm.2025.07.027

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.